MAS review group incentives could pull in regional biotech, fintech players: observers
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, too
Add BT as a preferred source
MARKET watchers believe tax incentives proposed by the Monetary Authority of Singapore’s (MAS) equities market review group will appeal to regional companies across a wide range of industries, including biotech, fintech and renewable energy.
“Sectors that rely on long-term capital, high-growth equity, and sustained liquidity post-listing stand to benefit the most,” said Kelvin Lee, co-founder and CEO of investment platform Alta.
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants as well. These firms often require long-term capital and investor confidence – qualities that Singapore’s financial ecosystem can provide, Ooi Chee Keong, Forvis Mazars Singapore partner and capital markets head, told The Business Times.
TRENDING NOW
Father-and-son duo Raj Kumar and Kishin in exclusive due diligence to buy Scotts Square
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Koh Brothers Eco Engineering faces up to S$57.6 million in potential legal liabilities
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry
